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Alexithymia is a personality trait characterized by difficulties in identifying and describing feelings and is associated
with psychiatric and psychosomatic disorders. The mechanisms underlying the link between emotional
dysregulation and psychosomatic disorders are unclear. Recent progress in neuroimaging has provided important
information regarding emotional experience in alexithymia. We have conducted three brain imaging studies on
alexithymia, which we describe herein. This article considers the role of emotion in the development of physical
symptoms and discusses a possible pathway that we have identified in our neuroimaging studies linking
alexithymia with psychosomatic disorders. In terms of socio-affective processing, alexithymics demonstrate lower
reactivity in brain regions associated with emotion. Many studies have reported reduced activation in limbic areas
(e.g., cingulate cortex, anterior insula, amygdala) and the prefrontal cortex when alexithymics attempt to feel other
people’s feelings or retrieve their own emotional episodes, compared to nonalexithymics. With respect to primitive
emotional reactions such as the response to pain, alexithymics show amplified activity in areas considered to be
involved in physical sensation. In addition to greater hormonal arousal responses in alexithymics during visceral
pain, increased activity has been reported in the insula, anterior cingulate cortex, and midbrain. Moreover, in
complex social situations, alexithymics may not be able to use feelings to guide their behavior appropriately. The
Iowa gambling task (IGT) was developed to assess decision-making processes based on emotion-guided evaluation.
When alexithymics perform the IGT, they fail to learn an advantageous decision-making strategy and show reduced
activity in the medial prefrontal cortex, a key area for successful performance of the IGT, and increased activity in
the caudate, a region associated with impulsive choice. The neural machinery in alexithymia is therefore activated
more on the physiologic, motor-expressive level and less in the cognitive-experiential domains of the emotional
response system. Affects may play an important role in alleviating intrinsic physiologic reactions and adapting to
the environment. Deficient development of emotional neural structures may lead to hypersensitivity to bodily
sensations and unhealthy behaviors, a possible mechanism linking alexithymia to psychosomatic disorders.
Keywords: Affect, Alexithymia, Emotional dysregulation, Neuroimaging, Psychosomatic disordersIntroduction
The alexithymia concept was introduced by Sifneos [1]
from the clinical observation of patients with classic
psychosomatic diseases, in which they failed to respond
to dynamic psychotherapy. It was conceptualized as
encompassing a cluster of cognitive traits including diffi-
culty identifying feelings, difficulty describing feelings to
others, externally oriented thinking, and a limited im-
aginative capacity [2]. Research investigating the alex-
ithymia construct has advanced rapidly, owing to the* Correspondence: kano-m@med.tohoku.ac.jp
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distribution, and reproduction in any mediumdevelopment of the self-reported, 20-item, Toronto
Alexithymia Scale (TAS-20) [3,4]. The TAS-20 provides
investigators with a reliable, validated, and common
metric for measuring the construct [5,6]. Individuals
with a TAS-20 total score of ≥61 are considered alex-
ithymic, and those with a score of <51 are considered
nonalexithymic [7]. The TAS-20 comprises three sub-
scales: difficulty identifying feelings, difficulty describing
one’s feelings, and presence of externally oriented thinking
[5,6]. Alexithymia was assessed by the TAS-20 in the stud-
ies addressed in this article. However, we note some
researchers question whether self-report measures of alex-
ithymia, including the TAS-20, provide a valid assessmentntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Kano and Fukudo BioPsychoSocial Medicine 2013, 7:1 Page 2 of 9
http://www.bpsmedicine.com/content/7/1/1of the construct and recommend the use of multiple
methods of measurement [8,9]. Various instruments have
been developed, such as observer-rated measures includ-
ing the modified Beth Israel Hospital Psychosomatic
Questionnaire (BIQ), the Observer Alexithymia Scale, a
set of Rorschach variables and the Toronto Structured
interview for Alexithymia [10]. The Levels of Emotional
Awareness Scale (LEAS) is also a self-report instrument to
elicit written emotional response and often compared to
the TAS-20 [11].
Although alexithymia is personality trait independent
from clinical diseases, a high rate of alexithymia has
been reported in several medical conditions and psychi-
atric disorders such as asthma, hypertension, and chronic
pain [5,6]. In particular, it is an important phenomenon in
a relevant subgroup of patients with functional somatic
disorders including functional gastrointestinal disorders
[12-15]. It is also associated with increased mortality
[16,17]. The prevalence of alexithymia is approximately
10% in the general population, whereas a high rate of alex-
ithymia (approximately 40–60%) is reported among
patients with psychosomatic disorders [7,12]. Alexithymia
is considered a key element associated with the psycho-
somatic process [18,19] and appears to play a role in
neurologic causes of physical illness [20].
The mechanism underlying alexithymia and its associ-
ation with physical illness remain to be elucidated. Never-
theless, several pathways have been suggested, as follows:
alexithymia leads to organic disease via physiologic or be-
havioral mechanisms; alexithymia leads to illness behavior
(physical symptoms, disability, and excessive health care
use) via cognitive or social mechanisms; physical illness
leads to alexithymia; both alexithymia and physical illness
result from sociocultural or biologic factors [20].
Physiologically, because the main problem of alexithy-
mic personality traits is considered to be deficit in affect
regulation, it is hypothesized that alexithymia constitutes
a longstanding risk factor for imbalances in the auto-
nomic nervous system and the neuroendocrine system
[15]. The few immunology studies that have been con-
ducted have found that alexithymia is associated with
poor immune status [5], and a number of studies have
found that alexithymia is related to increased levels of
resting (tonic) sympathetic or cardiovascular activity [5].
Recent progress in neuroimaging studies on alexithymia
has provided important information on the neural basis
of alexithymia. In particular, a number of studies have
examined brain responses underlying affect dysregula-
tion in alexithymia [21-36]. In addition to dysfunction of
the autonomic nervous system and neuroendocrine sys-
tem, we now consider that the alexithymic brain may
cause a variety of psychosomatic disorders. Here we re-
view recent neuroimaging findings related to emotional
experience in alexithymia, including those from three ofour own studies on emotional processing, visceral pro-
cessing, and emotion-guided decision-making, and dis-
cuss a possible neural mechanism linking alexithymia
and psychosomatic processes. In contrast to the many
studies focused on the personality dimensions of alex-
ithymia, we would like to provide a unique review of
alexithymia from the view point of the linking alexithy-
mia to somatic conditions.
Socio-affective processing in alexithymia
Research has repeatedly shown impairment of emotional
processing in alexithymia, that is, in the recognition of
basic emotions associated with emotionally valenced sen-
tences, words, faces, and scenes [37-39]. Therefore, in our
first experiment we conducted a brain imaging study of
facial expression processing in alexithymia, in which re-
gional cerebral blood flow (rCBF) was measured by posi-
tron emission tomography (PET) [22]. Subjects performed
gender discrimination of angry, sad, and happy facial
expressions, as well as neutral faces, during PET scanning;
thus, the emotional component of stimuli was assessed
implicitly. Alexithymics exhibited lower rCBF in the right
hemisphere in the inferior and middle frontal cortex, orbi-
tofrontal cortex, superior temporal gyrus, inferior parietal
cortex, and fusiform gyrus compared to nonalexithymics.
In addition, alexithymics showed higher rCBF in the left
hemisphere in the superior frontal cortex, inferior parietal
cortex, superior temporal gyrus, and cerebellum com-
pared to nonalexithymics. There was no significant differ-
ence in rCBF between alexithymics and nonalexithymics
when they looked at neutral faces. Moreover, the dorsal
anterior cingulate cortex (dACC) and bilateral insula were
less activated in alexithymics in response to angry faces
compared to their responses to neutral faces. The process
underlying the recognition of emotion in faces has been
characterized [40]. Lateral portions of the inferior occipital
gyrus, fusiform gyrus, and superior temporal gyrus are dis-
proportionately activated in facial processing [40]. The
amygdala is particularly activated in response to facial
expressions of fear, and the orbitofrontal cortex and ACC
are activated by facial expressions of anger [40]. The right
primary and secondary somatosensory areas, insula, and
anterior supramarginal gyrus are involved in the recogni-
tion of emotion [40].
Therefore, our above findings indicate that alexithy-
mics show dampened responses in emotional facial pro-
cessing regions in the right hemisphere and increased
responses in those areas in the left hemisphere. In addition,
the dACC has been suggested to play a crucial role in con-
scious awareness of emotion [41,42], and dysfunction in
the dACC has been proposed to be one of the main
mechanisms of alexithymia [8]. The anterior insula appears
to be critically involved in subjective emotional experience
and awareness of the internal bodily state [43-46]. Hence,
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areas associated with emotional awareness during the
viewing of facial expressions.
With regard to socio-affective processing, a number of
studies have demonstrated different brain responses in
areas associated with emotional processing. For example,
activity in the amygdala is reduced in alexithymics dur-
ing the viewing of a masked, sad face [31,34], in viewing
pictures evoking anxiety and disgust [47], in response to
threatening emotional actions [30], and with respect to
positive autobiographic recall [29]. In addition, it has
been reported that a female cocaine user showed a nega-
tive correlation between activity in the right amygdala
and alexithymia score in script-guided imagery of neu-
tral or stressful situations [48]. Reports of individuals
with high-functioning autism/Asperger syndrome also
demonstrate that alexithymia score is negatively corre-
lated with activity in the left amygdala during the rating
of affective pictures [49]. The amygdala plays a central
role in several aspects of emotional processing, such as
the recognition of both positively and negatively valenced
emotional stimuli [50,51]. Less activation in the insula is
also reportedly associated with alexithymia in response to
a masked, sad face [31] and in response to affective pic-
tures among individuals with autism [49]. Many studies
have reported alteration in activity in the ACC during
socio-affective tasks. Among these, 50% report a negative
correlation, 40% report a positive correlation, and 10%
show both types of associations (ie, high-alexithymia indi-
viduals showed more activation of the rostral ACC,
whereas low-alexithymia individuals showed more activa-
tion of the dACC) [30]. Activity in the dACC has been
reported to be increased in response to implicit presenta-
tion of facial expressions [52], in contrast to our results.
These discrepancies may be related to experimental
variables including tasks and stimuli. For example,
higher activation in the dACC and lower activation in
the amygdala has been shown to be associated with
alexithymia in the same experiment. Depending on the
context of the socio-affective task, dACC activity may
increase or decrease. The function of the dACC may
not always be associated with emotional awareness;
sometimes the ACC interacts with other parts of the
brain to sustain self-regulation of one’s own emotional
state. The above, taken together with our results, pro-
vide accumulating evidence for dysfunction in regions
related to socio-affective processing in alexithymia.
Interoceptive arousal in alexithymia
Somatosensory amplification
Another well-reported characteristic of alexithymia is
somatosensory amplification. Research has shown that
patients with chronic pain have higher levels of alexithy-
mia than control subjects, and alexithymia is associatedwith overreporting of physical symptoms [13,20,53-55].
An association between alexithymia and increased pain
intensity and sensitivity to experimentally induced pain
has been demonstrated [56-58]. The degree of alexithy-
mia correlates with the score of somatosensory amplifi-
cation [59]. Therefore, alexithymics might perceive signals
from the body in an aberrant manner such that low-
intensity stimulation is perceived as high intensity. In
particular, functional gastrointestinal disorders, such as ir-
ritable bowel syndrome, characterized by chronic gastro-
intestinal symptoms with no biochemical abnormalities,
are associated with alexithymia [14,60,61].
Therefore, in our second study, we investigated brain
responses to visceral stimulation induced by colonic dis-
tension between alexithymics and nonalexithymics. Dur-
ing colonic distension, greater activation was observed
in the pregenual ACC, right insula, and midbrain in sub-
jects with alexithymia [19]. The TAS-20 score correlated
positively with both activity in the right insula and or-
bital gyrus and adrenaline levels in the blood in response
to stimulation. Subjects with high scores for difficulty
identifying feelings perceived strong pain, urgency for
defecation, stress, and anxiety.
Visceral stimulation, especially by colonic distension,
has been reported to elicit activation of various brain
areas including the posterior insula, prefrontal cortex
(PFC), ACC, and brainstem periaqueductal gray (PAG)
[62-64]. A detailed, dynamic representation of particular
internal bodily states and the mapping of each intero-
ceptive state occurs within the orbitofrontal and right
insular cortices [65,66]. In the cingulate cortex, the
pregenual ACC responds to visceral stimulation and is
associated with the perception of secondary pain, which
is characterized by greater unpleasantness [67]. Elec-
trical stimulation of the insula has been reported to elicit
changes in blood pressure, heart rate, respiration, gastric
motility, peristaltic activity, salivation, and adrenaline se-
cretion [68]. In addition, the orbitofrontal cortex has been
shown to receive robust sensory input and to act as an
internal environmental integrator that coordinates be-
havioral, autonomic, and endocrine responses [69]. The
brainstem is known to control ascending nociceptive in-
put and nuclei such as the rostral ventromedial medulla
and PAG, which are able to both inhibit and facilitate
nociceptive responses. In particular, activation of the
right PAG has been reported to correlate with anxiety
during visceral stimulation but not somatic stimulation
[70]. Therefore, it may be assumed that activation of
brain areas associated with alexithymia represents affer-
ent representation of bodily states and efferent auto-
nomic and endocrine responses that accompany it.
Alexithymics may be more aroused by interoception of
unpleasant feelings than nonalexithymics, thereby dis-
playing more autonomic responses.
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tion hypothesis of alexithymia. There have been no other
imaging studies investigating pain or interoception pro-
cessing in alexithymia. However, a few, in which intero-
ceptive or physiologic arousal was induced, have provided
suggestive findings. Moriguchi et al. examined brain
responses of alexithymics during visual perception of pic-
tures depicting human hands and feet in painful situations
[26]. In this task assessing empathy to others’ pain, alex-
ithymics showed greater brain activity in the posterior and
anterior insula. The posterior insula is the primary end-
point of the interoceptive pathway, which represents sen-
sory aspects from the body including pain, touch, and
visceral sensation [43,65]. The information in the posterior
insula is rerepresented in the right anterior insular cortex,
which provides subjective awareness of the feelings from
the body, that is, metarepresentation of interoception
[43,65]. Other brain areas in the pain matrix, such as the
dorsolateral PFC, dorsal pons, and left caudal ACC, which
are associated with modulation of pain sensations, are less
activated, and the pain rating is lower in alexithymics [26].
Yet, the greater activity in the insula indicates a stronger
response in the representation of the internal physiologic
state in alexithymics [26].
There are overlapping characteristics of deficits in emo-
tional experience and expression between posttraumatic
stress disorder (PTSD) and alexithymia [7,8]. Frewen
et al. investigated functional neural responses to trauma
script imagery associated with severity of alexithymia in
a subsample of 26 individuals with PTSD [71]. The
TAS-20 score was correlated with increased activity in
the right posterior insula and ventral posterior cingulate
and decreased activity in the bilateral ventral ACC,
ventromedial PFC (vmPFC), anterior insula, and right
inferior frontal cortex [71]. Correlation between alex-
ithymic score and right insular activation might be
associated with centrally represented body-state map-
ping of sympathetic arousal, coupled with reduced ex-
ecutive–regulatory cognitive–affective control via the
ventral ACC, medial (mPFC), and right inferior frontal
cortex [43,45,65,66].
Both Moriguchi’s [22] and Frewen’s [70] studies men-
tioned above provide further evidence that alexithymia is
associated with greater activation in the insular cortex
representing interoceptive arousal in response to the in-
ternal body-state condition. Interestingly, a recent study
measured empathic brain responses in subjects with aut-
ism spectrum disorder and control subjects, in which
participants anticipated their partner’s pain, which was
indicated by an anticipatory cue (colored arrow) [72].
Activity in the anterior insula during the task was nega-
tively correlated with individual differences in TAS score
in both subjects with autism spectrum disorder and con-
trol subjects [72]. It is quite an interesting phenomenonthat real pain and pictures of painful stimuli or a trau-
matic event induce hyperactivity in the posterior insula,
whereas imagination of a partner’s pain provokes less ac-
tivation in the anterior insula associated with alexithy-
mia. This gradation of activity in the insular cortex
accompanying the gradation of the real level of pain
appears to explain alexithymic features remarkably. With
regard to pain experience, alexithymics may experience
pain more strongly at a primitive perceptual level and
may not be able to experience pain at a more abstract,
conceptual, formal, operational stage. This phenomenon
matches the theory of deficient affect development in
alexithymia [7,11].
Interoceptive awareness
Another notable finding with respect to interoception in
alexithymia is interoceptive awareness. Interoceptive
awareness tasks measure the ability to perceive (count)
one’s heartbeat and represents general sensitivity to vis-
ceral processes [73]. Neuroimaging studies have revealed
that the anterior insular cortex is of relevance for intero-
ceptive awareness and the rerepresentation and integra-
tion of interoceptive bodily signals with higher-order
and emotional processes [66]. Interestingly, the heartbeat
perception score was inversely correlated with alexithy-
mia in 155 university student subjects, suggesting that
alexithymics have less interoceptive awareness [73]. This
finding appears to be inconsistent with our results, in
which alexithymics show hyperinteroceptive arousal
during visceral pain. The discrepancy may be owing to
the nature of the tasks. The arousal level of interocep-
tion is different; the heartbeat detection task appears to
be less arousing than the visceral pain condition. The
heartbeat detection task measures attention processing
of interoception more and visceral pain processing mea-
sures the perception process more. Alexithymics may
feel interoceptive arousal more when the bodily state is
strongly aroused, or there might be some uncoupling
between the attention system and the perception system
to bodily signals. Whether activity in the anterior or
posterior insular cortex in alexithymia is less or more
during the heartbeat detection task should be examined
in the future.
Chronic pain and alexithymia
Although our results provide evidence that alexithymics
may be hypersensitive to interoceptive arousal, recent
reports suggest that alexithymia may be related mainly
to the affective—rather than the sensory—dimension of
chronic pain [20,55]. However, it has been reported that
alexithymia is associated with responses to sustained,
high-intensity stimuli (pain tolerance level) but not to
low-intensity stimuli (pain threshold level) in fibromyal-
gia [74]. Enhanced sensitivity to unpleasant sensations in
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during high-intensity stimulation or after prolonged pain
stimulation [56]. Association between alexithymia and
chronic pain syndromes cannot be explained simply by
hypersensitivity to sensory components of painful condi-
tions. Neuroimaging data indicate not only hyperactivity
in visceral perception areas, such as the insular cortex,
but also hypoactivity in pain-processing, regulatory areas
such as prefrontal cortex. Lack of an emotional regula-
tion system might cause hypersensitivity to aversive
bodily sensations and prolonged, pain-related affective
reactions such as distress. This is a possible mechanism
underlying the association between alexithymia and
chronic pain.
Decision-making process based on emotion-guided
evaluation in alexithymia
The regulation of emotions has been conceptualized as
an integrative, interactional process among the three
domains of the emotional response system and with the
environment. Affect regulation is a process involving
reciprocal interactions between the neurophysiologic,
motor-expressive, and cognitive-experiential domains of
the emotional response system. Because activation in
any one response domain alters or modulates activation
in the other two domains, all three domains are involved
in the regulation of emotion. Clearly, social bonds, lan-
guage, dreams, fantasy, play, crying, smiling, and defense
mechanisms all play roles in emotional regulation, as
does afferent feedback from peripheral autonomic activ-
ity and the musculoskeletal system [7]. Affects have im-
portant organizing, motivating, and adaptive functions.
Studies that we discuss in this article focus on one do-
main of the emotional response system, such as response
to facial expression for the cognitive-experiential domain
or response to visceral pain for the neurophysiologic
domain. The true problem in alexithymia, affect dysre-
gulation, is not a simple deficit in one domain of the
emotional response system. It is a dysfunction in the
interactions among each domain and a dysfunction in
the interaction between the emotional response system
and the environment. In a third neuroimaging study on
alexithymia, we investigated the ability to use emotional
signals to guide behavior in social situations.
The Iowa gambling task (IGT) was developed to assess
how the decision-making process is influenced by emo-
tionally biased signals, from the observation of patients
with damage to the vmPFC [75]. Such decision-making
as seen in the IGT presupposes the theory of “somatic
markers,” as developed by Damasio [76]. This theory
argues that optimal decision-making is not simply the
result of rationally, cognitively calculated categorization
of gains and losses but is also based on good or bad
affective reactions and emotionally guided evaluation.The decision-making deficits found after vmPFC damage
owe to an inability to use emotion-based biasing signals
generated from the body (somatic markers) when ap-
praising different response options. The reasoning is
influenced by crude biasing signals arising from the
neural machinery that underlies emotion.
Participants with alexithymia fail to learn an advanta-
geous decision-making strategy, with performance differ-
ing significantly from the nonalexithymic group in the
last IGT trial [76]. Comparing performance on the IGT
and the control task, both groups show brain activation
in areas associated with IGT including the PFC, supple-
mentary motor area, inferior parietal lobe, fusiform
gyrus, and cerebellum [77]. In addition, nonalexithymics
show activation in the bilateral insula and ACC, which
have been proposed to house some of the neural sub-
strates of somatic markers. However, alexithymics dem-
onstrate no activation in the insula or ACC but do show
activation in the caudate. Comparison between alexithy-
mics and nonalexithymics reveals that alexithymics show
lower rCBF in the vmPFC (Brodmann area [BA] 10) and
higher rCBF in the caudate and occipital areas during a
learning phase of IGT trials [24].
In the context of IGT-related processing, BA10 activity
may be associated with the use of internal signals ac-
companying affective evaluation of stimuli, which is cru-
cial for successful decision-making. The difference in
BA10 activity indicates that subjects with alexithymia
cannot use brain functions related to emotion-based
biasing signals. However, the function of the caudate is
to regulate or control impulsivity and disinhibition, and
its activity during decision-making has been suggested
to be a marker of risk attitude. Individuals with alexithy-
mia may work on the IGT impulsively rather than by
using emotion-based signals. This IGT study suggests
that individuals with alexithymia may be unable to use
feelings to guide their behavior appropriately, in addition
to being unable to recognize emotions, which supports
previous findings.
There is some behavioral data to support our findings.
Undergraduate students (N = 326) performed the stand-
ard IGT and a version in which cumulative financial
feedback was obscured [78]. Standard learning on the
IGT was observed for those scoring low for alexithymia.
Higher alexithymia scores were associated with an atte-
nuated learning rate on the IGT, especially under condi-
tions of reduced cognitive information. Those scoring
high for alexithymia showed a pattern of response
choices that indicated increased risk-taking toward the
end of the task [78]. The cognitive skills required to ef-
fectively monitor and self-regulate emotions are encom-
passed in a construct known as emotional intelligence.
The emotional intelligence score is inversely correlated
with the TAS-20 score [78]. Patients with lesions in
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cantly lower emotional intelligence (high TAS-20 score)
and poorer judgment in decision-making, as well as
disturbances in social functioning, compared to those
with lesions in structures outside the somatic marker
circuitry [79].
Taken together, alexithymic individuals may be unable
to use emotion for flexible cognitive regulation. Thus,
there may be uncoupling or dysfunction in the inter-
action of the aspects of the emotional response system
in alexithymia.
Cognitive emotional development model and alexithymia
Lane and Schwartz [80] conceptualized a cognitive-
development model for understanding the organization
of emotional experience (Figure 1A). In this model, the
experience of emotion is hypothesized to undergo struc-
tural transformation in a hierarchical developmental
sequence of progressive differentiation and integration.
There are five levels of emotional organization and aware-
ness in the model: awareness of physical sensations (level
1), action tendencies (level 2), single emotions (level 3),
blends of emotions (level 4), and blends of blends of emo-
tional experience (level 5, the capacity to appreciate com-
plexity in the experiences of self and others). The levels
are hierarchically related in that functioning at each level
adds to and modifies function of the previous levels but
does not eliminate them.
Each level of organization corresponds to an identifi-
able neurobiologic state. Levels 1 and 2 involve implicit
processes that are automatic, modular, and cognitively
impenetrable. Subcortical structures may participate in
the automatic generation of emotional responses asso-
ciated with absent or diffusely undifferentiated awareness.
Neural substrates of level 1 may include the thalamus andFigure 1 A: Schema for the five levels of emotional awareness model
organization of emotional experience and its neural substrates. The s
and modulates lower levels but does not replace them. Although each mo
level in the psychological and neuroanatomical models is not intended. Lo
Higher levels with gray background correspond to explicit processes. B: Ne
Alexithymics showed weak responses in structures of highly cognitive stag
affective processing), and stronger responses in primitive stages such as hy
alexithymics experience inflexible cognitive regulation, owing to impairmen
vmPFC = ventromedial prefrontal cortex.hypothalamus (diencephalon) and brainstem. At level 2,
the sensorimotor enactive level, the thalamus, amygdala,
and ventral striatum would be involved in association with
crude distinctions between globally positive and globally
negative states. Emotions at level 2 are represented in
actions, and the basal ganglia participate in the automatic
behavioral displays of emotional expression. Orbitofrontal
cortex activity appears to be associated with the percep-
tion of bodily sensations that bias behavior. For example,
orbitofrontal cortex activity affects behavior by overriding
automatic processes in the amygdala.
Levels 3 through 5 involve explicit processes that are
influenced by higher cognitive processes, including prior
knowledge. They are hypothesized to be mediated by the
structures at levels 1 and 2 and by paralimbic structures,
including the ACC and insula, and the mPFC. The ros-
tral ACC/mPFC appears to be necessary for the repre-
sentation of emotion used in conscious cognition. The
process of representational redescription is mediated, in
part, by structures involved in explicit processing at levels
3 through 5. Because these structures are not uniquely
devoted to the processing of emotion, their emotion-
related functions are cognitively penetrable. The level of
emotional awareness of a given individual may be a func-
tion of the degree to which these structures are or are not
devoted to processing of emotional information from the
internal and external worlds. The hierarchical nature of
this anatomic model is parallel to the hierarchical struc-
ture of the psychologic model.
Conclusions
We have conducted three brain imaging studies on alex-
ithymia. The first study displayed weakness of cognitive
emotional processing, with less activation in the dACC
and anterior insula during the viewing of angry facialof Lane and Schwartz [80], Parallels in the hierarchical
hell structure is intended to convey that each succeeding level adds to
del contains five levels, a one-to-one correspondence between each
wer levels with white background correspond to implicit processes.
ural machinery characterized by neuroimaging studies on alexithymia.
es, such as the capacity to feel other’s emotional reactions (socio-
persensitivity to visceral pain (interoceptive aroursal). Consequently
t of the emotional guiding system. ACC = Anterior cingulate cortex;
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mature stages such as levels 3 through 5. The second
study showed stronger awareness of visceral sensation in
alexithymics, with greater activity in the brainstem, poster-
ior insula, and rostral ACC, accompanying stronger auto-
nomic responses. This indicates stronger responses at
primitive stages such as levels 1 and 2. The third study
demonstrated greater activation in the caudate (basal
ganglia) and less activation in the mPFC in alexithymics
during the IGT, which may represent impairment of the
interactive, integrative process among the five levels. Thus
alexithymics show weak responses in structures necessary
for the representation of emotion used in conscious
cognition and stronger responses at levels focused on
action. Consequently, alexithymics experience inflexible
cognitive regulation, owing to impairment of the emotion-
guiding system.
The problem in alexithymia has been posited to be de-
ficient development of the cognitive mature stage, which
allows some rudimentary form of emotional experience,
such as high arousal of bodily sensations. Our neuroima-
ging studies provide neural evidence for this hypothesis
(Figure 1B). A mature emotional system might have a
role in alleviating physical sensations and in guiding
flexible behavior. Deficient emotional development in
alexithymia might lead to hypersensitivity to bodily sensa-
tions and unhealthy behaviors, which may be a possible
link between alexithymia and psychosomatic disorders.
Alexithymia has been linked with psychiatric conditions,
including high-functioning autism/Asperger syndrome
and depression, in addition to somatoform disorders [81].
Asperger’s syndrome is characterised by core disturbances
in speech and language and problems with affective inter-
action and has been indicated to have an overlapping
character with alexithymia [82,83]. In terms of socio-
affective processing, Asperger’s syndrome has similar fea-
tures to alexithymia. Patients with Asperger’s syndrome
showed failure to use information from faces, such as
facial affect, eye gaze and facial expression [84], and
anomalous activity in the amygdala, fusiform gyrus, and
superior temporal gyrus during facial expression recogni-
tion [85]. As mentioned above, during anticipation of the
partner’s pain, the strength of the signal in the anterior in-
sula was predictive of the degree of alexithymia in both
autistic and control groups [72]. However, there was no
difference between autistic and control groups after
accounting for alexithymia, suggesting that the empathy
deficits observed in autism may be due to the large
comorbidity between alexithymic traits and autism, rather
than representing a necessary feature of the social impair-
ments in autism [72]. In contrast to the reactivity in the
amygdala in individuals with alexithymia, many studies
have demonstrated hyperactivity in the amygdala in re-
sponse to negative facial expressions [86-89] and inresponse to other negative emotional stimuli [90,91] in
depressed subjects. Recent studies in adolescents with de-
pression [92,93] and at risk for depression [94] have con-
firmed that amygdala hyper-responsivity is present in the
early stages of illness. Alexithymia has been reported to be
associated strongly with depression in both general and
clinical populations [6]. It has also been reported that TAS
scores increased during depression and decreased after
remission [95] and closely linked to concurrent depressive
symptoms [96]. However, TAS scores did not predict
diagnoses of major depression in a 7-year follow-up study
[96]. Co-mobility of depressive disorder cannot explain
the neurobiological features of alexithymia. On the other
hand, recent study has shown less activity in somatoform
patients in the emotional brain circuit, including the
bilateral parahippocampal gyrus, the left amygdala, the left
superior temporal gyrus, and the insula, during facial emo-
tion recognition. Somatoform patients exhibited increased
alexithymia scores (TAS-20) and elevated depression
scores (BDI) [97]. Therefore, their neurobiological features
to emotional stimuli were more similar to alexithymia.
This article considers the role of emotion in the devel-
opment of physical symptoms and discusses a possible
pathway that we have identified in our neuroimaging
studies linking alexithymia with psychosomatic disor-
ders. The Alexithymia construct should be further inves-
tigated, not only as psychological problems in affect
regulation but also from the viewpoint of an association
with physiological symptoms.
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